Lindberg Anne, Linder Robert, Backman Helena, Eriksson Ström Jonas, Frølich Andreas, Nilsson Ulf, Rönmark Eva, Johansson Strandkvist Viktor, Behndig Annelie F, Blomberg Anders
Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden.
Department of Public Health and Clinical Medicine, Division of Occupational and Environmental Medicine, Umeå University, Umeå, Sweden.
Eur Clin Respir J. 2017 Dec 17;4(1):1415095. doi: 10.1080/20018525.2017.1415095. eCollection 2017.
: Chronic obstructive pulmonary disease (COPD) is a largely underdiagnosed disease including several phenotypes. In this report, the design of a study intending to evaluate the pathophysiological mechanism in COPD in relation to the specific phenotypes non-rapid and rapid decline in lung function is described together with the recruitment process of the study population derived from a population based study. : The OLIN COPD study includes a population-based COPD cohort and referents without COPD identified in 2002-04 ( = 1986), and thereafter followed annually since 2005. Lung function decline was estimated from baseline in 2002-2004 to 2010 (first recruitment phase) or to 2012/2013 (second recruitment phase). Individuals who met the predefined criteria for the following four groups were identified; group A) COPD grade 2-3 with rapid decline in FEV and group B) COPD grade 2-3 without rapid decline in FEV (≥60 and ≤30 ml/year, respectively), group C) ever-smokers, and group D) non-smokers with normal lung function. Groups A-C included ever-smokers with >10 pack years. The intention was to recruit 15 subjects in each of the groups A-D. : From the database groups A-D were identified; group A = 37, group B = 29, group C = 41, and group D = 55. Fifteen subjects were recruited from groups C and D, while this goal was not reached in the groups A ( = 12) and B ( = 10). The most common reasons for excluding individuals identified as A or B were comorbidities contraindicating bronchoscopy, or inflammatory diseases/immune suppressive medication expected to affect the outcome. : The study is expected to generate important results regarding pathophysiological mechanisms associated with rate of decline in lung function among subjects with COPD and the in-detail described recruitment process, including reasons for non-participation, is a strength when interpreting the results in forthcoming studies.
慢性阻塞性肺疾病(COPD)是一种在很大程度上未被充分诊断的疾病,包含多种表型。在本报告中,描述了一项旨在评估COPD中与肺功能非快速和快速下降这两种特定表型相关的病理生理机制的研究设计,以及来自一项基于人群研究的研究人群的招募过程。:OLIN COPD研究纳入了一个基于人群的COPD队列以及在2002 - 2004年确定的无COPD的对照人群(n = 1986),此后自2005年起每年进行随访。肺功能下降情况是从2002 - 2004年的基线水平评估到2010年(第一招募阶段)或2012/2013年(第二招募阶段)。确定了符合以下四组预定义标准的个体;A组)FEV快速下降的2 - 3级COPD患者,B组)FEV无快速下降(分别≥60和≤30 ml/年)的2 - 3级COPD患者,C组)曾经吸烟者,以及D组)肺功能正常的非吸烟者。A - C组包括吸烟史超过10包年的曾经吸烟者。计划在A - D组每组招募15名受试者。:从数据库中确定了A - D组;A组 = 37人,B组 = 29人,C组 = 41人,D组 = 55人。从C组和D组招募了15名受试者,而A组(n = 12)和B组(n = 10)未达到这一目标。将被确定为A或B组的个体排除的最常见原因是存在禁忌支气管镜检查的合并症,或预期会影响结果的炎症性疾病/免疫抑制药物。:该研究有望得出关于COPD患者肺功能下降速率相关病理生理机制的重要结果,并且详细描述的招募过程,包括不参与的原因,在解释后续研究结果时是一个优势。